Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2021

01-08-2021 | Cholecystitis | Case Report

Cholecystocolonic fistula as an uncommon cause of diarrhea: a case-report and review of the literature

Authors: Chansong Choi, Karim Osman, Christopher Pierce Hartley, Daniel Barry Maselli

Published in: Clinical Journal of Gastroenterology | Issue 4/2021

Login to get access

Abstract

Bilio-enteric fistulization is the aberrant connection between the biliary and luminal digestive tracts. The cholecystocolonic fistula (CCF) is the second most common bilio-enteric fistula (comprising 20% of cases), after the cholocystoduodenal fistula (comprising 70% of all cases). A CCF may result from malignancy or more benign etiologies, such as gallstones, and is thought to arise from a chronic inflammatory cadence of tissue necrosis, tissue perforation, and fistula creation. The combination of chronic watery diarrhea, vitamin K malabsorption, and radiological evidence of pneumobilia in a patient with history of gallstone disease has been suggested as a pathognomonic triad of CCF. Here, we present a case of a 62-year-old woman exhibiting this triad, who was found to have a CCF as a result of chronic gallstone-related disease. Recognition of this rare etiology of chronic diarrhea can enhance clinicians’ diagnostic appraisal and management of this common chief complaint.
Literature
1.
go back to reference Antonacci N, Taffurelli G, Casadei R, et al. Asymptomatic cholecystocolonic fistula: a diagnostic and therapeutic dilemma. Case Rep Surg. 2013;2013:754354.PubMedPubMedCentral Antonacci N, Taffurelli G, Casadei R, et al. Asymptomatic cholecystocolonic fistula: a diagnostic and therapeutic dilemma. Case Rep Surg. 2013;2013:754354.PubMedPubMedCentral
2.
go back to reference Savvidou S, Goulis J, Gantzarou A, et al. Pneumobilia, chronic diarrhea, vitamin K malabsorption: a pathognomonic triad for cholecystocolonic fistulas. World J Gastroenterol. 2009;15:4077–82.CrossRef Savvidou S, Goulis J, Gantzarou A, et al. Pneumobilia, chronic diarrhea, vitamin K malabsorption: a pathognomonic triad for cholecystocolonic fistulas. World J Gastroenterol. 2009;15:4077–82.CrossRef
3.
go back to reference Costi R, Randone B, Violi V, et al. Cholecystocolonic fistula: facts and myths. A review of the 231 published cases. J Hepatobiliary Pancreat Surg. 2009;16:8–18.CrossRef Costi R, Randone B, Violi V, et al. Cholecystocolonic fistula: facts and myths. A review of the 231 published cases. J Hepatobiliary Pancreat Surg. 2009;16:8–18.CrossRef
4.
go back to reference Vijayvargiya P, Camilleri M. Current practice in the diagnosis of bile acid diarrhea. Gastroenterology. 2019;156:1233.CrossRef Vijayvargiya P, Camilleri M. Current practice in the diagnosis of bile acid diarrhea. Gastroenterology. 2019;156:1233.CrossRef
5.
go back to reference Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver. 2015;9:332.CrossRef Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver. 2015;9:332.CrossRef
6.
go back to reference Angrisani L, Corcione F, Fau Tartaglia A, Fau Tricarico A, et al. Cholecystoenteric fistula (CF) is not a contraindication for laparoscopic surgery. Surg Endosc. 2001;15:1023.CrossRef Angrisani L, Corcione F, Fau Tartaglia A, Fau Tricarico A, et al. Cholecystoenteric fistula (CF) is not a contraindication for laparoscopic surgery. Surg Endosc. 2001;15:1023.CrossRef
7.
go back to reference Yamashita H, Chijiiwa K, Fau Ogawa Y, Kuroki S, et al. The internal biliary fistula–reappraisal of incidence, type, diagnosis and management of 33 consecutive cases. HPB Surg. 1997;10:143.CrossRef Yamashita H, Chijiiwa K, Fau Ogawa Y, Kuroki S, et al. The internal biliary fistula–reappraisal of incidence, type, diagnosis and management of 33 consecutive cases. HPB Surg. 1997;10:143.CrossRef
8.
go back to reference Baratta VM, Kurbatov V, Le Blanc JM, et al. Robotic cholecystectomy and cholecystoenteric fistula closure in a female with remote cholangitis. J Surg Case Rep. 2019;2019:rjz231.CrossRef Baratta VM, Kurbatov V, Le Blanc JM, et al. Robotic cholecystectomy and cholecystoenteric fistula closure in a female with remote cholangitis. J Surg Case Rep. 2019;2019:rjz231.CrossRef
9.
go back to reference Velayos Jiménez B, Gonzalo Molina Ma Fau - Carbonero Díaz P, Carbonero Díaz P Fau - Díaz Gutiérrez F, et al. Cholecystocolic fistula demonstrated by barium enema: an uncommon cause of chronic diarrhoea. Velayos Jiménez B, Gonzalo Molina Ma Fau - Carbonero Díaz P, Carbonero Díaz P Fau - Díaz Gutiérrez F, et al. Cholecystocolic fistula demonstrated by barium enema: an uncommon cause of chronic diarrhoea.
10.
go back to reference Caroli-Bosc FX, Ferrero Jm Fau - Grimaldi C, Grimaldi C Fau - Dumas R, et al. Cholecystocolic fistula: from symptoms to diagnosis. Caroli-Bosc FX, Ferrero Jm Fau - Grimaldi C, Grimaldi C Fau - Dumas R, et al. Cholecystocolic fistula: from symptoms to diagnosis.
Metadata
Title
Cholecystocolonic fistula as an uncommon cause of diarrhea: a case-report and review of the literature
Authors
Chansong Choi
Karim Osman
Christopher Pierce Hartley
Daniel Barry Maselli
Publication date
01-08-2021
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 4/2021
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01413-7

Other articles of this Issue 4/2021

Clinical Journal of Gastroenterology 4/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine